Issue 003 | U.S. Pilot | US

IMA

ImageneBio, Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-07 Filing currency: USD
Internal NCAV Discount 42.3%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
122,006,000USD
Total Liabilities
13,355,000USD
NCAV
108,651,000USD
Cash
76,048,000USD
NCAV per share
9.69USD/share
Evidence
5 annual | 22 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
2
Unavailable
7
Requires inspection Negative OCF -14,800,000
Latest
-14,800,0002026-03-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-212073

Supporting observation Current Ratio > 1.5 18.39
Latest
18.392026-03-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001193125-26-212073

7 unavailable checks — inspect missing inputs
High Debt (short-term debt + long-term debt) / ordinary equity >= 50%
Low Debt (short-term debt + long-term debt) / ordinary equity < 20%
Material 1Y Share Increase 1Y share change >= +2% using the same share-count source
NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source
Non-Positive Equity ordinary shareholders equity <= 0
Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Historical values can be viewed as reported in each filing or normalized to the latest verified split basis. These are measurement aids, not conclusions about a company.

Policy: normalize_to_latest_verified_split_basis | quality: verified

Display basis

Verified split events: reverse 12.0 on 2026-03-31

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
Revenue 800,000 3,500,000 9,160,000 15,618,000 30,985,000
Operating Income -48,451,000 -58,973,000 -75,417,000 -70,904,000 -34,138,000
Net Income -45,349,000 -49,234,000 -68,166,000 -68,765,000 -34,115,000
Cash From Operations -47,844,000 -46,004,000 -79,743,000 -74,109,000 -60,252,000
Capex n/a -414,000 -414,000 -1,431,000 -1,760,000
Free Cash Flow n/a -46,418,000 -80,157,000 -75,540,000 -62,012,000
Cash And Equivalents 94,532,000 39,393,000 119,894,000 59,919,000 232,217,000
Accounts Receivable n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Total Current Assets 140,288,000 127,169,000 178,662,000 160,010,000 236,516,000
Total Assets 152,976,000 141,510,000 192,092,000 172,259,000 247,879,000
Total Current Liabilities 11,234,000 10,778,000 14,205,000 21,503,000 27,189,000
Total Liabilities 19,837,000 15,576,000 22,335,000 25,290,000 40,002,000
Shareholders Equity 133,139,000 125,934,000 169,757,000 146,969,000 207,877,000
Shares Outstanding 11,181,639 48,258,111 48,258,111 36,257,493 35,975,034
Shares Outstanding Diluted n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 4,870,906 48,258,111 41,735,081 36,188,420 27,983,359
Weighted Avg Shares Basic 4,870,906 48,258,111 41,735,081 36,188,420 27,983,359
Net Share Count Change (Normalized) -0.0% Insufficient evidence 9.4% 0.0% 0.3%
Ownership Claim Change (Normalized) 0.0% Insufficient evidence -8.6% 0.0% -0.3%
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-12-31
10-K
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue 800,000 n/a n/a 0 n/a 800,000 n/a n/a 3,500,000 2,004,000 5,313,000 658,000 1,185,000 2,004,000 5,313,000 5,450,000 6,402,000 382,000 3,384,000 20,216,000 3,746,000 3,549,000
Operating Income -12,079,000 -8,504,000 -2,313,000 -26,594,000 -8,750,000 -10,794,000 -12,517,000 -12,517,000 -12,407,000 -15,823,000 -18,226,000 -21,909,000 -19,503,000 -18,490,000 -15,515,000 -15,115,000 -17,876,000 -20,951,000 -16,962,000 2,791,000 -14,522,000 -12,687,000
Net Income -10,619,000 -6,908,000 -9,184,000 -24,779,000 -2,767,000 -8,619,000 -9,124,000 -9,124,000 -10,234,000 -13,730,000 -16,146,000 -19,489,000 -17,343,000 -17,115,000 -14,219,000 -14,097,000 -17,338,000 -20,491,000 -16,839,000 2,797,000 -14,515,000 -12,681,000
Cash From Operations -14,800,000 -7,218,000 -7,218,000 -26,642,000 -3,422,000 -10,562,000 -6,260,000 -6,260,000 -8,938,000 -12,502,000 -18,304,000 -21,819,000 -19,997,000 -18,143,000 -19,784,000 -17,655,000 -17,219,000 -19,451,000 -19,784,000 -13,368,000 -17,990,000 -15,724,000
Capex n/a n/a n/a n/a n/a n/a n/a n/a 0 0 -152,000 -262,000 0 0 -152,000 -231,000 -1,131,000 -36,000 -33,000 -550,000 -184,000 -187,000
Free Cash Flow n/a n/a n/a n/a n/a n/a n/a n/a -8,938,000 -12,502,000 -18,456,000 -22,081,000 -19,997,000 -18,143,000 -19,936,000 -17,886,000 -18,350,000 -19,487,000 -19,817,000 -13,918,000 -18,174,000 -15,911,000
Cash And Equivalents 76,048,000 94,532,000 94,532,000 103,162,000 58,290,000 36,763,000 39,393,000 39,393,000 45,190,000 44,268,000 52,852,000 119,894,000 121,277,000 70,868,000 29,329,000 59,919,000 67,074,000 48,487,000 46,877,000 232,217,000 245,899,000 264,004,000
Total Current Assets 122,006,000 140,288,000 140,288,000 147,532,000 99,013,000 116,999,000 127,169,000 127,169,000 141,533,000 149,321,000 161,166,000 178,662,000 200,634,000 160,646,000 141,178,000 160,010,000 177,978,000 199,145,000 216,050,000 236,516,000 251,865,000 268,710,000
Total Liabilities 13,355,000 19,837,000 19,837,000 21,046,000 10,259,000 12,588,000 15,576,000 15,576,000 14,756,000 14,626,000 17,435,000 22,335,000 28,146,000 15,064,000 17,379,000 25,290,000 31,680,000 36,816,000 34,792,000 40,002,000 58,442,000 62,567,000
Shares Outstanding n/a n/a 11,181,639 11,181,672 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 44,104,672 42,299,478 36,257,493 36,257,493 36,257,493 36,251,977 36,109,534 35,975,034 35,877,794 35,859,119
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 11,211,268 n/a 4,870,906 8,526,781 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 47,806,651 43,437,844 39,292,710 36,257,493 36,257,493 36,257,074 36,160,951 36,075,407 35,930,458 35,860,284 35,853,341
Weighted Avg Shares Basic 11,211,268 4,870,906 4,870,906 8,526,781 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 48,258,111 47,806,651 43,437,844 39,292,710 36,257,493 36,257,493 36,257,074 36,160,951 36,075,407 35,930,458 35,860,284 35,853,341
Net Share Count Change (Normalized) 2662.0% -0.0% -0.0% Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence 9.4% 4.3% Insufficient evidence Insufficient evidence 0.0% 0.0% 0.4% 0.4% 0.3% 0.1% Insufficient evidence
Ownership Claim Change (Normalized) -96.4% 0.0% 0.0% Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence -8.6% -4.1% Insufficient evidence Insufficient evidence 0.0% -0.0% -0.4% -0.4% -0.3% -0.1% Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 122,006,000USD us-gaap:AssetsCurrent 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Total Liabilities 13,355,000USD us-gaap:Liabilities 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Cash 76,048,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Shares Outstanding 11,211,268 us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding 2026-03-31 1.00 Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
NCAV 108,651,000USD derived 2026-03-31 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 9.69USD derived 2026-03-31 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 42.3% derived 2026-03-31 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / weighted_avg_shares_diluted

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001835579
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001835579/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
21
Imported At
2026-08-15T12:52:12+00:00
Rendered At
2026-08-16T03:29:48+00:00

Run Audit

Mary Run
8f67c1da7de642feb640d04491409c50
Mary As Of
2026-07-25
Accession
0001193125-26-212073
CIK
0001835579
Mary Filing Date
2026-05-07
Filing Currency
USD
Internal Discount
42.3%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=8f67c1da7de642feb640d04491409c50; mary_as_of=2026-07-25; mary_filing_date=2026-05-07; mary_accession=0001193125-26-212073; mary_cik=0001835579; gnni_supporting_filing_date=2026-05-07; internal_discount=0.42319; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive